Fredun Pharma strengthens presence in the Veterinary Healthcare Business with foray into Large Animal Products

Fredun Pharmaceuticals Limited (BSE: 539730), a leading provider of pharmaceuticals and innovative healthcare solutions for veterinary applications, announces its foray into the large animal veterinary segment, under the FREOSSI Large Animals brand with the launch of targeted products Freossi Tone+ and Freossi Power. FREOSSI has a strong & existing reputation in companion animal care, hence this will provide a foundation of trust and reliability when expanding into large animal products.

These new products have scientific & clinical evidence and are developed with the expertise of veterinary professionals in animal health. They specifically are designed to address key health challenges faced by livestock owners including lactation issues, quality of milk, joint stiffness, and mobility concerns.

Innovative Solutions for Large Animal Health

Freossi Tone +: Provides Lactation Solutions

A scientifically formulated supplement, Freossi Tone+ supports higher milk yield & better milk quality, improved lactation cycles, and overall skeletal and muscular health. Enriched with Microcrystalline Hydroxyapatite Complex (MCHC), proteins, collagens, and a proprietary blend with evaluated ratios of herbal extracts, it is ideal for cows, buffaloes, goats, and horses.

- Improves milk yield and addresses irregular or suppressed lactation
- Ensures lengthy lactation periods
- Prevents milk fever and postpartum haemorrhage
- Significantly improves milk fat percentage

Freossi Power: Strength and Mobility for Livestock

Freossi Power is designed to alleviate joint stiffness, lameness, and inflammation in large animals. Its active ingredients Microcrystalline Hydroxyapatite Complex (MCHC) including Glucosamine Sulphate USP and Methylsulfonylmethane (MSM), support joint health, flexibility, and endurance, making it ideal for horses, bulls, ponies, and cattle.

- Relieves joint stiffness, lameness, weakness, and inflammation
- Reduces pain in conditions like osteoarthritis
- Enhances stamina, flexibility, and range of motion
- Strengthens joint cartilage

Commenting on the Development, Mr. Fredun Medhora, Managing Director, said: "Our foray into the large animal healthcare space is a strategic step in expanding Fredun Pharma's presence in veterinary healthcare, while reinforcing our commitment to innovation and quality. With Freossi Tone + and Freossi Power, we are addressing key challenges faced by livestock owners while promoting the overall advancement of animal health. This marks an important milestone as we work towards offering specialized solutions across the broader veterinary spectrum."

Following this launch, Fredun Pharma is actively expanding its footprint in veterinary healthcare, moving beyond pet care to develop a comprehensive portfolio for large animals. With a pipeline of new products tailored to meet evolving industry needs, the Company aims to establish itself as a key player in the livestock health segment, delivering effective and science-based solutions.

Freossi a division of Fredun Pharma launched in 2021, specializes in premium-quality pet nutrition, animal feed additives, and veterinary healthcare formulations. The brand is known for its range of Microcrystalline Hydroxyapatite Complex (MCHC)-based formulations, backed by over 60 years of clinical research, ensuring proven efficacy in animal nutrition and health.

Shares of Fredun Pharmaceuticals Ltd was last trading in BSE at Rs. 673.80 as compared to the previous close of Rs. 679.50. The total number of shares traded during the day was 3007 in over 91 trades.

The stock hit an intraday high of Rs. 679.45 and intraday low of 660.15. The net turnover during the day was Rs. 2019697.00.

Source : Equity Bulls

Keywords

FredunPharmaceuticals INE194R01017 Pharmaceuticals VeterinaryApplications FREOSSI LargeAnimalsBrand